FDA Approves Azedra for Treatment of Rare Adrenal Tumors
CMS Issues CY 2019 Proposed OPPS Rule
GAO Report Compares Characteristics of 340B and non-340B Hospitals
House of Representatives Passes PCHETA, Three Other Workforce Bills
FDA Approves Filgrastim Biosimilar for AML
CMS to Host Webinar Series on 2017 MIPS Feedback; 2018 Performance Categories
FDA Approves Ivosidenib for R/R AML
FDA Approves Ribociclib in Combination for Advanced, Metastatic Breast Cancer
ACCC Submits Comments to Administration's Drug Pricing Blueprint
FDA Approves Enzalutamide for Castration-resistant Prostate Cancer
CMS Issues Proposed CY2019 Physician Fee Schedule & QPP Rule
ACS Launches Series to Outline 21st-Century Blueprint for Cancer Control
NCI, VA Come to Agreement to Improve Veterans' Access to Cancer Clinical Trials
GAO Reports Calls for More Oversight of 340B Contract Pharmacies
CMS Posts MIPS Final Scores, Performance Feedback for Review
CMS Advances Demonstration to Waive MIPS Requirements for Clinicians in Certain At-Risk Medicare Advantage Plans
FDA Approves Encorafenib/Binimetinib Combo for Advanced Melanoma with BRAF Mutation
ACCC Submits Comments to CMS on NCA for CAR T Therapy
FDA Approves Bevacizumab in Combination with Chemotherapy for Ovarian Cancer
FDA Approves Pembrolizumab for Advanced Cervical Cancer
ACCC In the Press at ASCO 2018
FDA Approves Venetoclax for CLL, Small Lymphocytic Lymphoma
American Cancer Society Updates Colorectal Cancer Screening Guideline
FDA Approves Abiraterone Acetate to Treat Metastatic Castration-Resistant Prostate Cancer
